ACAD vs CDNS · P/E 15, rev $957.8M vs P/E 82, rev $5.30B
ACADIA Pharmaceuticals Inc (ACAD) versus Cadence Design Systems Inc (CDNS) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US.
Latest reported ACAD revenue for 2024-12-31 was $957.8M. Net income was $226.5M. Revenue was up 314.6% from 2023-12-31 to 2024-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
Not investment advice. Open the ACAD and CDNS stock pages for the full models.
Not investment advice.